SAN FRANCISCO—The stigma of serious mental illness affects treatment decisions of both mental health care providers and primary care providers, according to a new research poster presented at the American Psychiatric Association (APA) meeting.
SAN FRANCISCO—The Suicide Trigger Scale-Version 3 (STS-3) showed significant validity in predicting whether or not psychiatric inpatients would attempt suicide.
Merck & Co's experimental insomnia drug moved a step closer to U.S. approval on Wednesday after a panel of medical experts said it is effective and safe at lower doses.
